These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9917756)

  • 1. Screening asymptomatic, middle-aged men for carcinoma of the prostate: can we all stop shouting out our answer for a minute and think about the question?
    Whittington R
    Med Pediatr Oncol; 1999 Jan; 32(1):60-2. PubMed ID: 9917756
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for carcinoma of the prostate.
    Alexander FE
    Med Pediatr Oncol; 1999 Jan; 32(1):63-4. PubMed ID: 9917757
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate carcinoma practice patterns: what do they tell us about the diagnosis, treatment, and outcomes of patients with prostate carcinoma?
    Wilt TJ
    Cancer; 2000 Mar; 88(6):1277-81. PubMed ID: 10717606
    [No Abstract]   [Full Text] [Related]  

  • 4. Voluntary screening program for prostate cancer: detection rate and cost.
    Abramson N; Cotton S; Eckels R; Baldock J
    South Med J; 1994 Aug; 87(8):785-8. PubMed ID: 7519789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSA screening--current controversy.
    Svetec D; Thompson IM
    Ann Oncol; 1998 Dec; 9(12):1283-8. PubMed ID: 9932156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prostate cancer.
    Morton GC
    Curr Probl Cancer; 2000; 24(1):5-51. PubMed ID: 10749454
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer.
    Hahnfeld LE; Moon TD
    Med Clin North Am; 1999 Sep; 83(5):1231-45, vi. PubMed ID: 10503062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.
    Roemeling S; Roobol MJ; Postma R; Gosselaar C; van der Kwast TH; Bangma CH; Schröder FH
    Eur Urol; 2006 Sep; 50(3):475-82. PubMed ID: 16713065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facing up to prostate cancer.
    Ficorelli CT; Weeks B
    Nursing; 2006 May; 36(5):66-8. PubMed ID: 16670611
    [No Abstract]   [Full Text] [Related]  

  • 10. Current management of prostatic carcinoma.
    Bahnson RR; Catalona WJ
    Prim Care; 1985 Dec; 12(4):795-813. PubMed ID: 3909178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: A challenge for screening.
    Donnell RF
    Surg Oncol Clin N Am; 1999 Oct; 8(4):693-702, vii. PubMed ID: 10452935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic cancer.
    Olsson C
    Kidney Int; 1993 Apr; 43(4):955-65. PubMed ID: 7683069
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostatic carcinoma.
    Lawton CA; Grignon D; Newhouse JH; Schellhammer PF; Kuban DA
    Radiographics; 1999; 19(1):185-203. PubMed ID: 9925399
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate cancer: screening and treatment options.
    Horger DC; Clarke HS
    J S C Med Assoc; 2003 Apr; 99(4):85-7. PubMed ID: 12762154
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinoma of the prostate: overview of the most common malignancy in men.
    Carson CC
    N C Med J; 2006; 67(2):122-7. PubMed ID: 16752715
    [No Abstract]   [Full Text] [Related]  

  • 16. Early prostate cancer diagnosis and therapy.
    Glodé LM
    Adv Intern Med; 2000; 45():41-64. PubMed ID: 10635045
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer screening in Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuprorelin three-month depot in the treatment of advanced and metastatic prostate cancer: long-term follow-up results.
    Jocham D
    Urol Int; 1998; 60 Suppl 2():18-24; discussion 35. PubMed ID: 9607554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?
    Schriefer P; Steurer S; Huland H; Graefen M
    J Clin Oncol; 2012 Nov; 30(32):e341-4. PubMed ID: 23032622
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostate carcinoma].
    Huland H
    Dtsch Med Wochenschr; 1994 Apr; 119(16):605. PubMed ID: 7512895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.